GHO acquires X-Chem

By The Science Advisory Board staff writers

June 3, 2020 -- Global Healthcare Opportunities (GHO) has acquired X-Chem, a biotechnology company that provides drug discovery services via DNA-encoded library technology.

GHO plans to increase its technology and service proposition following the completion of the acquisition, according to the company.

X-Chem's proprietary DNA-encoded library platform contains over 200 billion small molecules that it can leverage for drug discovery services.

Matt Clark, co-founder of X-Chem and its current senior vice president, will be named its chief executive officer (CEO). Rick Wagner, co-founder and CEO of X-Chem, will resign from the company.

Ligand, Roche to develop ion channel drug discovery platform
Ligand Pharmaceuticals and Icagen have expanded Icagen's license agreement with Roche to develop and commercialize small molecule ion channel modulators...
AbCellera raises $105M to fund antibody drug development
Artificial intelligence-powered biotech and drug discovery platform AbCellera has closed a $105 million series B financing round to expand its capacity...
AbCellera partners with Lilly for antibody discovery
AbCellera Biologics has joined forces with Eli Lilly on a multiyear initiative to identify antibodies for up to nine therapeutic targets.
New platform includes biological similarities to accelerate drug discovery
A new open-access tool provides information on the effects of nearly 1 million compounds in a wide range of biological settings. The new tool, published...
X-Chem, ALK partner on allergy drug discovery
X-Chem announced on February 5 a new drug discovery partnership with ALK-Abelló A/S. The collaboration will focus on the discovery of small-molecule...

Copyright © 2020

Register below for our weekly Letter from the Editor to receive the latest Science news and insights.
BioProcess International Europe
July 13-17
Central European Time Zone (CET) Netherlands
2020 ACCP Annual Meeting
September 20-22
Bethesda, Maryland United States
Bioprocess International West
September 21-24
Eastern Standard Time Zone (EST) United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter